Dr. John Hoffman

Nuclear Medicine
Office
50 N Medical Dr, 
Salt Lake City, UT 
Office
50 N Medical Dr, 
Salt Lake City, UT 

Overview

John Hoffman is a Nuclear Medicine provider practicing medicine in Salt Lake City, Utah.

His clinical expertise encompasses Venous Thromboembolism (VTE).

He is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 14 clinical trials.

Specialties

Nuclear Medicine

Licenses

Nuclear Medicine in UT

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
50 N Medical Dr, Salt Lake City, UT 84132
Other Locations
Office
1950 Circle Of Hope Dr Ste 6810, Salt Lake City, UT 84112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Development of an Integrated Molecular Biomarker ofEarly Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients Using Imaging Assessments and Genomic Modeling
Development of an Integrated Molecular Biomarker ofEarly Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients Using Imaging Assessments and Genomic Modeling
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Radiation, Drug
Study Drugs: Erlotinib, Bevacizumab
Study Phase: Phase 1
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
Enrollment Status: Terminated
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: 18F-Fluciclovine, 18F-FLT
Study Phase: Phase 1/Phase 2
Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial
Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial
Enrollment Status: Terminated
Publish Date: December 09, 2024
[18F]Fluciclovine Companion Imaging Study to Radium-223 and Radiotherapy in Hormone-Naive Men With Oligometastatic Prostate Cancer to Bone (RROPE) Study
[18F]Fluciclovine Companion Imaging Study to Radium-223 and Radiotherapy in Hormone-Naive Men With Oligometastatic Prostate Cancer to Bone (RROPE) Study
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Drug, Procedure
Study Drug: Fluciclovine
Study Phase: Phase 2
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
Enrollment Status: Terminated
Publish Date: November 20, 2024
Intervention Type: Drug, Diagnostic test
Study Drugs: [18F]Flutemetamol, [18F]fluoro-2-deoxy-D-glucose
Study Phase: Phase 2
Assessment of Primary and Metastatic Brain Tumor Hypoxia With 18F-Fluoromisonidazole, [18F]Fluoro-2-deoxy-D-glucose (FDG) and [15O]Water (H215O)
Assessment of Primary and Metastatic Brain Tumor Hypoxia With 18F-Fluoromisonidazole, [18F]Fluoro-2-deoxy-D-glucose (FDG) and [15O]Water (H215O)
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 1
Multi-tracer PET Assessment of Response in Various Malignancies in Investigational and Recently Approved Therapeutic Agents
Multi-tracer PET Assessment of Response in Various Malignancies in Investigational and Recently Approved Therapeutic Agents
Enrollment Status: Terminated
Publish Date: April 17, 2024
Intervention Type: Radiation, Procedure
Study Phase: Not Applicable
A Multi-modality Imaging Assessment of Chemobrain
A Multi-modality Imaging Assessment of Chemobrain
Enrollment Status: Completed
Publish Date: March 15, 2024
Intervention Type: Drug
Study Phase: Phase 1
Implications for Management of PET Amyloid Classification Technology
Implications for Management of PET Amyloid Classification Technology
Enrollment Status: Completed
Publish Date: April 24, 2023
Intervention Type: Drug
Multi-Tracer Positron Emission Tomography (PET) Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
Multi-Tracer Positron Emission Tomography (PET) Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
Enrollment Status: Completed
Publish Date: October 15, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

63 Total Publications

Altered functional connectivity is associated with Repeatable Battery for the Assessment of Neuropsychological Status across the dementia spectrum.
Altered functional connectivity is associated with Repeatable Battery for the Assessment of Neuropsychological Status across the dementia spectrum.
Journal: Journal of the International Neuropsychological Society : JINS
Published: April 01, 2026
Similar Doctors
Expertise in
1
conditions
Dr. Peggy Chan
Nuclear Medicine
Expertise in
1
conditions
Dr. Peggy Chan
Nuclear Medicine
Referral may be required

University Of Utah Hospital Radiology Department

50 N Medical Dr, 
Salt Lake City, UT 
 (0.1 miles away)
801-587-7109
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Peggy Chan is a Nuclear Medicine provider practicing medicine in Salt Lake City, Utah. Dr. Chan is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Lung Nodules, Smoldering Multiple Myeloma, Classical Hodgkin Lymphoma, and Gastroesophageal Junction Cancer. Dr. Chan is board certified in American Board Of Neurological Surgery. Dr. Chan is currently accepting new patients.

Expertise in
0
conditions
Dr. Andrew Kozlov
Nuclear Medicine
Expertise in
0
conditions
Dr. Andrew Kozlov
Nuclear Medicine
Referral may be required

University Of Utah Hospital Radiology Department

50 N Medical Dr, 
Salt Lake City, UT 
 (0.1 miles away)
801-587-7109
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrew Kozlov is a Nuclear Medicine provider practicing medicine in Salt Lake City, Utah. His clinical expertise encompasses Breast Lump, Galactocoele, Pleurisy, and Pleural Effusion. Dr. Kozlov is board certified in American Board Of Radiology. Dr. Kozlov is currently accepting new patients.

Expertise in
0
conditions
Dr. Isis Gayed
Nuclear Medicine
Expertise in
0
conditions
Dr. Isis Gayed
Nuclear Medicine
Referral may be required

University Of Utah Health

50 N Medical Dr, 
Salt Lake City, UT 
 (0.1 miles away)
801-585-6387
Languages Spoken:
English
See accepted insurances

Isis Gayed is a Nuclear Medicine provider practicing medicine in Salt Lake City, Utah. Her clinical expertise encompasses Melorheostosis, Melorheostosis with Osteopoikilosis, Osteopenia, Mantle Cell Lymphoma (MCL), and Gallbladder Removal.

Frequently Asked Questions about Dr. John Hoffman

How do I make an appointment with Dr. John Hoffman?

You can book an appointment with Dr. John Hoffman by calling their office at 801-581-7553. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John Hoffman a top-rated expert for Venous Thromboembolism (VTE)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John Hoffman is classified as an Experienced expert for Venous Thromboembolism (VTE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John Hoffman specialize in?

While Dr. John Hoffman is a Nuclear Medicine, they have specific expertise in Venous Thromboembolism (VTE). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nuclear Medicine.

Does Dr. John Hoffman participate in research or clinical trials?

Yes. Dr. John Hoffman has published 63 articles and abstracts on conditions like Venous Thromboembolism (VTE). You can view a list of Dr. John Hoffman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hoffman's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile